The Basics difference between Gem/Cis with Durvalumab vs. Keytruda By Steve|2024-10-11T16:07:49+13:00November 18th, 2023|Categories: All, Updates, Z-Legacy|Tags: immunotherapy| Read More 2
PBAC Recommends IMFINZI (durvalumab) for Cholangiocarcinoma Patients in Australia By Steve|2024-10-11T16:07:53+13:00August 29th, 2023|Categories: All, Media, Updates, Z-Legacy|Tags: durvalumab| Read More 0